MedPath
HSA Approval

NAC MEVON 600 MG EFFERVESCENCE TABLETS

SIN15645P

NAC MEVON 600 MG EFFERVESCENCE TABLETS

NAC MEVON 600 MG EFFERVESCENCE TABLETS

March 15, 2019

NOVEM PHARMA PRIVATE LIMITED

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM PHARMA PRIVATE LIMITED
Licence HolderNOVEM PHARMA PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET, EFFERVESCENT

ORAL

Medical Information

R05CB01

acetylcysteine

Manufacturer Information

NOVEM PHARMA PRIVATE LIMITED

E-Pharma Trento S.p.A.

Active Ingredients

Acetylcysteine

600mg

Acetylcysteine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NAC MEVON 600 MG EFFERVESCENCE TABLETS - HSA Approval | MedPath